2m 2m 2m 2m 2m 2m 2m
Myriad Genetics (MYGN)
NASDAQ
$3.42-$0.005 (-0.15%)
Price as of Sep 11, 2026 7:50 PM EDT- $327.1MMarket Cap
- -52.76%1-Year Change
- Diagnostics & ResearchIndustry
Myriad Genetics (MYGN)
$3.42-$0.005 (-0.15%)
MYGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.42 | ||
Change | +$0.06 (+1.79%) | ||
Open | $3.37 | ||
High | $3.42 | ||
Low | $3.19 | ||
Previous Close | $3.36 | ||
Volume | 2,552,959 | ||
30-Day Average Volume | 1,664,620 | ||
1-Week Change | 7.21% | ||
1-Month Change | 6.21% | ||
1-Year Change | -52.76% | ||
3-Year Change | -79.03% | ||
5-Year Change | -89.71% | ||
Fundamentals | |||
Shares Outstanding | 95.6M | ||
Total Assets | $638.9M | ||
Market Cap | $327.1M | ||
Enterprise Value | $332.6M | ||
Period: QTR TTM FY | |||
Revenue | $190.7M | ||
Net Income | -$43.2M | ||
Free Cash Flow | -$8.3M | ||
EBIT | -$42.6M | ||
EBITDA | -$30.1M | ||
Net Working Capital | $158.3M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | 0 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 03/26/2009 | ||
Earnings & Revenue